NeOnc Technologies: Funding, Investors & Team (Sep 2026)
NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other nontraditional delivery of a novel, highly purified form of monoterpenes (oils from fruits & plants), alone or with other chemotherapeutics (cancer treatment chemicals) agents. It will initially be used in clinical research for first-line treatment of malignant brain cancer (gliomas) and other aggressive brain cancers, and later for the treatment of lung cancer. NTI was incorporated in the State of Delaware in 2008. The Company has assembled a highly qualified management team and board of directors. NTI is developing several proprietary molecules for clinical research some of which have demonstrated significant activity (positive results) in laboratory tests; NTI is accordingly building a portfolio of intellectual property around this research. In addition, the Company has reached an agreement with a manufacturer of active pharmaceutical ingredients for the development and production of proprietary monoterpenes.
NeOnc Technologies has raised $28.5M across 2 funding rounds on record, the most recent an undisclosed round of $18.5M announced in Jun 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NeOnc Technologies Company Profile and Key Stats
Latest funding round on record: Jun 2024.
NeOnc Technologies Funding Rounds
NeOnc Technologies raised $10.0M in an undisclosed round announced in Feb 2023.
1.3 years later, an undisclosed round of $18.5M was announced in Jun 2024.
NeOnc Technologies Founders and Leadership Team
No contact details are on record for this team yet.
NeOnc Technologies Funding Compared to Other Biotechnology Startups
NeOnc Technologies' latest round of $18.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NeOnc Technologies in Biotechnology and Woodland Hills
Companies Similar to NeOnc Technologies
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
NeOnc Technologies Funding FAQs
What does NeOnc Technologies do?
NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other nontraditional delivery of a novel, highly purified form of monoterpenes (oils from fruits & plants), alone or with other chemotherapeutics (cancer treatment chemicals) agents. It will initially be used in clinical research for first-line treatment of malignant brain cancer (gliomas) and other aggressive brain cancers, and later for the treatment of lung cancer. NTI was incorporated in the State of Delaware in 2008. The Company has assembled a highly qualified management team and board of directors. NTI is developing several proprietary molecules for clinical research some of which have demonstrated significant activity (positive results) in laboratory tests; NTI is accordingly building a portfolio of intellectual property around this research. In addition, the Company has reached an agreement with a manufacturer of active pharmaceutical ingredients for the development and production of proprietary monoterpenes.
How much funding has NeOnc Technologies raised?
NeOnc Technologies has raised $28.5M across 2 rounds on record. The most recent is an undisclosed round of $18.5M announced in Jun 2024.
When did NeOnc Technologies last raise funding?
NeOnc Technologies' most recent funding round on record is an undisclosed round of $18.5M, announced in Jun 2024.
Who founded NeOnc Technologies?
FundedIQ lists Thomas C Chen (Founder) at NeOnc Technologies.
Where is NeOnc Technologies headquartered?
NeOnc Technologies is based in Woodland Hills, California, United States.
How many employees does NeOnc Technologies have?
NeOnc Technologies is in the 1-10 employee band.
How does NeOnc Technologies' funding compare to other Biotechnology startups?
NeOnc Technologies' latest round of $18.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's NeOnc Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NeOnc Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.